Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Over the last 12 months, insiders at Bruker Corporation have bought $5.01M and sold $5.52M worth of Bruker Corporation stock.
On average, over the past 5 years, insiders at Bruker Corporation have bought $1.74M and sold $21.32M worth of stock each year.
Highest buying activity among insiders over the last 12 months: LAUKIEN FRANK H (PRESIDENT & CEO) — $5.01M.
The last purchase of 100,000 shares for transaction amount of $5.01M was made by LAUKIEN FRANK H (PRESIDENT & CEO) on 2024‑11‑18.
2024-12-02 | Sale | director | 3,350 0.0022% | $57.82 | $193,683 | +0.34% | ||
2024-11-18 | PRESIDENT & CEO | 100,000 0.0669% | $50.14 | $5.01M | -3.73% | |||
2024-08-15 | Sale | director | 4,684 0.0032% | $63.14 | $295,748 | 0.00% | ||
2024-03-04 | Sale | director | 15,000 0.0109% | $90.06 | $1.35M | -27.62% | ||
2024-02-28 | Sale | PRESIDENT, BIOSPIN GROUP | 28,122 0.0201% | $85.48 | $2.4M | -24.49% | ||
2024-02-22 | Sale | PRES. & CEO, BRUKER BEST | 15,319 0.011% | $83.30 | $1.28M | -21.88% | ||
2023-08-08 | Sale | PRESIDENT & CEO | 37,947 0.0256% | $64.81 | $2.46M | +4.70% | ||
2023-06-16 | Sale | EXECUTIVE VICE PRESIDENT, CFO | 14,242 0.0097% | $75.42 | $1.07M | -5.26% | ||
2023-05-19 | Sale | director | 11,146 0.0075% | $75.22 | $838,402 | -5.22% | ||
2023-05-16 | Sale | PRESIDENT & CEO | 14,625 0.0099% | $73.11 | $1.07M | -2.03% | ||
2023-05-15 | Sale | PRESIDENT & CEO | 185,375 0.1269% | $72.75 | $13.49M | -0.56% | ||
2023-05-09 | Sale | PRESIDENT & CEO | 110,982 0.0745% | $75.20 | $8.35M | -5.58% | ||
2023-05-08 | Sale | PRESIDENT & CEO | 89,018 0.0606% | $77.05 | $6.86M | -6.67% | ||
2023-05-03 | Sale | PRESIDENT & CEO | 16,435 0.0111% | $79.21 | $1.3M | -10.26% | ||
2023-05-02 | Sale | PRESIDENT & CEO | 100,770 0.0684% | $77.98 | $7.86M | -7.97% | ||
2023-05-01 | Sale | PRESIDENT & CEO | 82,795 0.0565% | $78.75 | $6.52M | -8.29% | ||
2023-04-25 | Sale | PRESIDENT & CEO | 51,770 0.0361% | $78.86 | $4.08M | -6.37% | ||
2023-04-24 | Sale | PRESIDENT & CEO | 148,230 0.1008% | $81.02 | $12.01M | -11.27% | ||
2023-01-17 | Sale | director | 921 0.0006% | $68.26 | $62,867 | +5.18% | ||
2022-12-06 | Sale | director | 20,000 0.0134% | $66.18 | $1.32M | +5.67% |
LAUKIEN FRANK H | PRESIDENT & CEO | 38439563 25.3562% | $58.83 | 89 | 16 | +27.04% |
PACKER RICHARD A | director | 80904 0.0534% | $58.83 | 2 | 3 | +5.57% |
Busse Falko | PRESIDENT, BIOSPIN GROUP | 32859 0.0217% | $58.83 | 0 | 1 | |
ROSENTHAL BOB | director | 30963 0.0204% | $58.83 | 0 | 1 | |
Requardt Hermann Fritz | director | 23147 0.0153% | $58.83 | 0 | 1 | |
Prause Burkhard | PRES. & CEO, BRUKER BEST | 17065 0.0113% | $58.83 | 0 | 4 | |
LAUKIEN DIRK D | 15862972 10.4638% | $58.83 | 1 | 7 | ||
LAUKIEN JOERG C | 15208795 10.0323% | $58.83 | 4 | 7 | +23.29% | |
LAUKIEN MARC M | 10 percent owner | 14506348 9.569% | $58.83 | 1 | 4 | |
LAUKIEN ISOLDE | 10 percent owner | 14160160 9.3406% | $58.83 | 1 | 3 | |
Srega Juergen | Group President Bruker CALID | 130936 0.0864% | $58.83 | 0 | 1 | |
WAGNER CHARLES F JR | EVP & Chief Financial Officer | 99925 0.0659% | $58.83 | 0 | 1 | |
Munch Mark | Exec VP&Pres Bruker Nano Inc. | 85064 0.0561% | $58.83 | 0 | 5 | |
KNIGHT WILLIAM J | Chief Financial Officer | 63350 0.0418% | $58.83 | 3 | 0 | +60.54% |
KNISS RICHARD | director | 40753 0.0269% | $58.83 | 0 | 2 | |
Herman Gerald N | EXECUTIVE VICE PRESIDENT, CFO | 36462 0.0241% | $58.83 | 0 | 1 | |
LINTON WILLIAM A | director | 29000 0.0191% | $58.83 | 1 | 0 | +24.86% |
Martin Gilles Gerard Jean | director | 14657 0.0097% | $58.83 | 0 | 1 | |
Friend Cynthia M | director | 11576 0.0076% | $58.83 | 0 | 7 | |
Lenggenhager Rene | President, BioSpin Group | 11037 0.0073% | $58.83 | 0 | 1 | |
Kastner Marc A | director | 8051 0.0053% | $58.83 | 0 | 6 | |
VAN INGEN CHRIS | director | 4577 0.003% | $58.83 | 0 | 2 | |
STEIN RICHARD M | Secretary | 3349 0.0022% | $58.83 | 0 | 2 | |
FURLONG BRENDA J | director | 1000 0.0007% | $58.83 | 0 | 1 | |
Emmerich Wolf-Dieter | director | 0 0% | $58.83 | 0 | 1 | |
Fesik Stephen W. | director | 0 0% | $58.83 | 0 | 1 |
T Rowe Price Investment Management Inc | $1.25B | 8.77 | 13.27M | +0.61% | +$7.62M | 0.76 | |
The Vanguard Group | $926.29M | 6.52 | 9.86M | -0.37% | -$3.41M | 0.02 | |
BlackRock | $912.56M | 6.42 | 9.71M | -1.11% | -$10.25M | 0.02 | |
Pallas Capital Advisors | $890.6M | 6.27 | 9.48M | +12.52% | +$99.12M | 39.91 | |
Fidelity Investments | $861.58M | 6.06 | 9.17M | -2.76% | -$24.49M | 0.06 | |
Massachusetts Financial Services Co Ma | $759.87M | 5.35 | 8.09M | +0.11% | +$826,390.18 | 0.23 | |
RTW Investments, LP | $314.14M | 2.21 | 3.34M | 0% | +$0 | 4.71 | |
State Street | $305.11M | 2.15 | 3.25M | +2.87% | +$8.51M | 0.01 | |
AllianceBernstein | $243.69M | 1.71 | 2.59M | +7.31% | +$16.6M | 0.09 | |
Invesco | $196.35M | 1.38 | 2.09M | +5.32% | +$9.92M | 0.04 | |
Fuller & Thaler Asset Management, Inc. | $195.14M | 1.37 | 2.08M | +10.01% | +$17.75M | 0.86 | |
London Co Of Virginia | $170.67M | 1.2 | 1.82M | +33,101.17% | +$170.15M | 0.9 | |
Td Asset Management Inc | $168.04M | 1.18 | 1.79M | +7.45% | +$11.65M | 0.15 | |
Geode Capital Management | $157.17M | 1.11 | 1.67M | +1.81% | +$2.79M | 0.01 | |
Brown Advisory | $145.15M | 1.02 | 1.55M | -2.83% | -$4.23M | 0.19 | |
Citadel Advisors LLC | $140.86M | 0.99 | 1.5M | -4.34% | -$6.39M | 0.08 | |
Congress Asset Management Co Ma | $132.87M | 0.94 | 1.41M | +3.46% | +$4.44M | 0.96 | |
Dimensional Fund Advisors | $110.45M | 0.78 | 1.18M | +0.42% | +$465,660.43 | 0.03 | |
Bank of America | $109.68M | 0.77 | 1.17M | +21.55% | +$19.45M | 0.01 | |
T. Rowe Price | $99.73M | 0.7 | 1.06M | -22.71% | -$29.3M | 0.01 | |
Goldman Sachs | $97.53M | 0.69 | 1.04M | -41.79% | -$70.02M | 0.02 | |
BNY Mellon | $88.13M | 0.62 | 938,199 | -3.64% | -$3.33M | 0.02 | |
Janus Henderson | $81.65M | 0.57 | 869,205 | +3.52% | +$2.78M | 0.04 | |
Ameriprise Financial | $76.57M | 0.54 | 815,075 | -7.41% | -$6.13M | 0.02 | |
First Trust | $76.65M | 0.54 | 815,897 | +13,343.68% | +$76.08M | 0.08 | |
Charles Schwab | $70.43M | 0.5 | 749,742 | +0.26% | +$182,243.60 | 0.02 | |
Morgan Stanley | $70.24M | 0.49 | 747,704 | +2.31% | +$1.59M | 0.01 | |
Marshall Wace | $57.3M | 0.4 | 609,988 | New | +$57.3M | 0.06 | |
Northern Trust | $56.82M | 0.4 | 604,834 | -13.11% | -$8.57M | 0.01 | |
Palisade Capital Management | $49M | 0.35 | 521,633 | -6.04% | -$3.15M | 1.46 | |
Iron Triangle Partners LP | $43.82M | 0.31 | 466,521 | +3.67% | +$1.55M | 4.66 | |
Epoch Investment Partners Inc | $43.86M | 0.31 | 466,865 | +15.15% | +$5.77M | 0.2 | |
Handelsbanken | $43.05M | 0.3 | 458,300 | +18.03% | +$6.58M | 0.19 | |
Alyeska Investment Group L P | $40.82M | 0.29 | 434,568 | -22% | -$11.51M | 0.25 | |
Montanaro Asset Management | $38.14M | 0.27 | 406,000 | -12.74% | -$5.57M | 6.89 | |
Colorado PERA | $33.65M | 0.24 | 358,200 | -1.06% | -$360,256.60 | 0.15 | |
Brown Brothers Harriman Co | $32.97M | 0.23 | 350,998 | +34.7% | +$8.49M | 0.25 | |
Vaughan Nelson Investment Management | $31.26M | 0.22 | 332,728 | +5.56% | +$1.65M | 0.28 | |
DekaBank | $28.69M | 0.2 | 307,040 | +0.6% | +$172,298.45 | 0.05 | |
Nuveen | $27.48M | 0.19 | 292,510 | -2.84% | -$802,811.26 | 0.01 | |
RhumbLine Advisers | $26.62M | 0.19 | 283,365 | -6.48% | -$1.84M | 0.02 | |
Grantham Mayo Van Otterloo & Co LLC | $24.95M | 0.18 | 265,583 | +29.7% | +$5.71M | 0.07 | |
AQR Capital | $23.21M | 0.16 | 248,447 | -6.34% | -$1.57M | 0.04 | |
New York State Common Retirement Fund | $21.83M | 0.15 | 232,361 | -4.93% | -$1.13M | 0.03 | |
Integral Health Asset Management Llc | $20.67M | 0.15 | 220,000 | +120% | +$11.27M | 2.07 | |
Eventide Asset Management | $19.76M | 0.14 | 210,362 | <0.01% | -$281.82 | 0.32 | |
Envestnet Asset Management Inc | $19.05M | 0.13 | 202,824 | +7.79% | +$1.38M | 0.01 | |
JPMorgan Chase | $18.95M | 0.13 | 201,710 | -7.24% | -$1.48M | <0.01 | |
CalPERS | $17.69M | 0.12 | 188,310 | -4.54% | -$840,762.98 | 0.01 | |
Legal & General | $17.54M | 0.12 | 186,733 | -9.69% | -$1.88M | <0.01 |